Evidence map›Paper›PMID 40187739›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2025

Longitudinal assessment of the effect of invasive fungal infections on transplant success in kidney transplant recipients.

Lucy X Li, Jiashu Xue, Teresa Po-Yu Chiang, Na Lu, Darin Ostrander, Sean X Zhang, John W Baddley, Shmuel Shoham, Daniel C Brennan, Christine M Durand and 4 more

Abstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lucy X LiDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: lli101@jh.edu.
Jiashu XueDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Teresa Po-Yu ChiangDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Center for Surgical and Transplant Applied Research, New York University Grossman School of Medicine, New York, New York, USA.
Na LuDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Darin OstranderDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sean X ZhangDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
John W BaddleyDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Shmuel ShohamDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Daniel C BrennanDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Christine M DurandDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
William A WerbelDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Kieren A MarrDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Elion Therapeutics, New York, New York, USA; Pearl Diagnostics, Baltimore, Maryland, USA.
Robin K AveryDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Nitipong PermpalungDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Funding

RESEARCH TRAINING IN MICROBIAL DISEASEST32AI007291 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JOEL N BLANKSON, Sara Elizabeth Cosgrove · 1986 to 2026
$9.1M
NIAID NIH HHS T32 AI007291
6 · The paper itself

Abstract

Invasive fungal infections (IFIs) significantly impact morbidity and mortality in kidney transplant recipients (KTRs), but their effect on allograft function remains poorly defined. This retrospective study examined adult KTRs transplanted at Johns Hopkins from 2012 to 2018, with follow-up through 2023. The association of IFIs with a composite outcome of graft failure and mortality was assessed using negative binomial regression. The association of IFI exposure on composite outcome was quantified by matching using a stochastic extension stratification method, followed by Cox regression. Among 1453 KTRs, 79 were diagnosed with proven/probable IFIs, predominantly invasive candidiasis (46.8%). KTRs with IFIs had worse outcome-free survival with higher composite outcome rates (53/79 [67.1%] vs 411/1338 [30.7%]; P < .001). The composite outcome incidence rate was 4.61-fold higher when IFIs occurred in the first 6 months posttransplant and decreased to 2.13-fold higher after 36 months (P < .001). IFI exposure was associated with 3.45-fold increased hazard of composite outcome (95% CI, 1.54-7.70; P < .01) and a 3.23-fold increased hazard of all-cause mortality (95% CI, 1.53-6.83; P < .01). The association of IFIs with increased risk of poor kidney transplant outcomes, particularly in the early posttransplant period, highlights the need for improved strategies for early IFI detection and management in KTRs.

Indexed as

Graft RejectionGraft SurvivalInvasive Fungal InfectionsKidney Failure, ChronicKidney TransplantationPostoperative ComplicationsAdultFemaleFollow-Up StudiesGlomerular Filtration RateHumansIncidenceKidney Function TestsLongitudinal StudiesMaleMiddle Agedinvasive fungal infectionkidney allograft functionkidney transplantation

Identifiers

PMID40187739
PMCPMC12310366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.